Quantcast
Last updated on April 18, 2014 at 21:21 EDT

Latest Microarrays Stories

2013-10-07 08:25:29

NEW YORK, October 7, 2013 /PRNewswire/ -- Editor Note: For more information about this release, please scroll to bottom. Today, Analysts' Corner announced new research reports highlighting BioMarin Pharmaceutical Inc. (NASDAQ: BMRN), Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY), Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX), Illumina, Inc. (NASDAQ: ILMN), and Intrexon Corporation (NYSE: XON). Today's readers may access these reports free of charge - including full...

2013-10-02 23:22:13

Reportbuyer.com just published a new market research report: Genetic Testing Market Outlook to 2017. London (PRWEB) October 02, 2013 A recent report, “Genetic Testing Market Outlook to 2017”, provides an in-depth analysis of the current and future genetic testing market. A comprehensive introduction of gene-based tests, their working principles and types are covered in around a 140-page report. On account of our analysis of the past and present market trends; drivers; and existing...

2013-09-30 23:34:30

Cancer/Tumor Profiling Market report categorizes the global cancer/tumor profiling market into geography, applications, technologies, and segment types. http://www.marketsandmarkets.com/Market-Reports/cancer-tumor-profiling-market-1250.html (PRWEB) September 30, 2013 The "Cancer/Tumor Profiling Market [Applications (Personalized Medicine, Diagnostics, Biomarker Discovery, Prognosis, Research), Technologies (NGS, QPCR, IHC, FISH/CISH, Microarray), Segments: Genomics, Proteomics,...

2013-09-30 08:28:55

Study Published in Nature Is First Showing Exomes Sequenced from Patients' Plasma Can Serve as Non-Invasive Biopsy to Track Evolution of Metastatic Cancer in Response to Therapy ANN ARBOR, Mich., Sept. 30, 2013 /PRNewswire/ -- Rubicon Genomics, Inc., a leader in the development and commercialization of innovative sample-specific nucleic acid library preparation products used in research and clinical testing, today reported that its ThruPLEX(TM)-FD Prep Kits contributed to the...

2013-09-26 23:27:01

Transparency Market Research published new "Molecular Cytogenetics Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019" market research report to its report store. Browse the report with complete TOC visit: http://www.transparencymarketresearch.com/molecular-diagnostics-market.html . Albany, New York, USA (PRWEB) September 26, 2013 Transparency Market Research published new market report “Molecular Cytogenetics Market (Technologies: FISH...

2013-09-26 08:27:11

DALLAS, September 26, 2013 /PRNewswire/ -- The "CANCER/TUMOR PROFILING MARKET [Applications (Personalized Medicine, Diagnostics, Biomarker Discovery, Prognosis, Research), Technologies (NGS, QPCR, IHC, FISH/CISH, Microarray), Segments: Genomics, Proteomics, Metabolomics, Epigenetics)] 2013 - 2018", report analyzes and studies the major market drivers, restraints, and adoption potential in North America, Europe, Asia, and Rest of the World. Browse market 22 data tables...

2013-09-23 16:24:17

Jefferies LLC Engaged as Financial Advisor SAN DIEGO, Sept. 23, 2013 /PRNewswire/ -- Sequenom, Inc. (NASDAQ: SQNM), a life sciences company providing innovative diagnostic testing and genetic analysis solutions, today announced that its Board of Directors has authorized a review of potential strategic alternatives for its Genetic Analysis business segment. The review will include evaluation of a full range of potential strategic alternatives for the Genetic Analysis business segment....

2013-09-18 08:28:34

SAN DIEGO, Sept. 18, 2013 /PRNewswire/ -- Sequenom, Inc. (NASDAQ: SQNM), a life sciences company providing innovative diagnostic testing and genetic analysis solutions, today announced a Certified Service Provider (CSP) program for the technical certification of selected laboratories offering research services using the Sequenom research-use-only MassARRAY(®) System. Certifications cover the major research applications of the MassARRAY System, including iPLEX(®) genotyping,...

2013-09-16 16:25:27

Affymetrix GeneChip(R) Human Transcriptome Service Provides High Density Gene Expression Data for Large Clinical Studies MORRISVILLE, N.C., Sept. 16, 2013 /PRNewswire/ -- Gentris Corporation (www.gentris.com), a global leader in pharmacogenomics and biorepository solutions, announced today that it is expanding its genomic biomarker offering with the launch of Affymetrix GeneChip((R)) Human Transcriptome Array (HTA) services. The GeneChip((R)) HTA is a high resolution microarray for...

2013-09-16 10:46:31

Kashin-Beck disease (KBD) and Keshan disease (KD) are major endemic diseases in China. Postgraduate Xi Wang et al., under the guidance of Professor Xiong Guo from the Institute of Endemic Diseases of the Faculty of Public Health, Medicine College of Xi'an Jiaotong University, Key Laboratory of Environment and Gene Related Diseases in Ministry of Education, Key Laboratory of Trace Elements and Endemic Diseases of Health Ministry, set out to tackle these two endemic diseases. After several...